|
Media, News, Press Release
Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech
Medmain Inc., a Japanese MedTech startup that offers PidPort, an AI-powered cloud system to assist in digital pathology, is pleased to announce that it has been selected for the “U.S. Market Gateway Accelerator for BioSciences and MedTech”, an acceleration program sponsored by WorldUpstart, LLC. We will take advantage of this opportunity to move forward with our business development in the U.S.
Fore more details:
https://www.prnewswire.com/news-releases/medmain-inc-has-been-selected-for-the-us-market-gateway-accelerator-for-biosciences-and-medtech-301923132.html
